Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today it will offer the Elecsys pTau181 test, the only blood test cleared by the U.S. Food and Drug ...

Labcorp Holdings (LH) posted a net profit margin of 6.2% for the period, up from 3.4% a year ago, as earnings surged 96.4% year-over-year. This is well above the company's five-year average despite a ...

BLS revenue reached $799 million, up 8.3%, and adjusted operating income grew to $132 million. The quarter ended with an $8.6 billion backlog, and the BLS book-to-bill was 0.89 for the quarter and ...

Labcorp to offer Roche and Eli Lilly’s Elecsys pTau181 blood test for Alzheimer’s, offering a less invasive alternative. Read more here.

Updates Full-Year Guidance Financial results from Operations for third quarter 2025 versus third quarter 2024: Revenue: $3.56 billion versus $3.28 billion ...

This guide lays out real price points from at-home MTHFR gene test kits and direct-access labs to doctor-ordered testing, then explains what you actually get ...

Scientists at CSIRO, Australia's national science agency, have identified simpler and less invasive methods to improve ...

Reports Q3 revenue $3.56B, consensus $3.56B. “Labcorp’s (LH) third-quarter performance reflects continued momentum in our Diagnostics and Central ...

Raises FY25 free cash flow view to $1.17B-$1.29B from $1.13B-$1.28B. The company said, “Labcorp (LH) is updating 2025 full year guidance to reflect its third quarter performance and full year outlook.

Here is everything we know about Elon Musk’s 14 children, who he shares with four partners: Justine Wilson, Grimes, Shivon ...

MIAMI, Oct. 29, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) (OPKO) reports business highlights and financial results for the three and nine months ended September 30, 2025. Highlights ...